Blade Ent Signs MOU with Gyeongnam Pharmaceutical for 'Electroceuticals and Digital Therapeutics STO' Business

Blade Ent announced on the 14th that it has signed a Memorandum of Understanding (MOU) with Gyeongnam Pharmaceutical to collaborate on the issuance of token securities (STO) for electroceuticals and digital therapeutics.

With this MOU, Blade Ent plans to develop Gyeongnam Pharmaceutical’s new business in digital therapeutics and electroceuticals by combining it with token securities into an “electroceutical and digital therapeutics token securities” business.

Electroceuticals is a compound word of electronic and pharmaceutical, referring to electronic devices that generate electrical signals in the brain and nerve cells to treat diseases. Instead of drugs or injections, it provides electrical stimulation without harming the human body and diagnoses and treats diseases by analyzing nerve electrical signals.

According to global market research firm IDTechEx, the global electroceuticals market is expected to grow more than 10% annually and reach $60 billion (approximately KRW 78.966 trillion) by 2029.

A Blade Ent official stated, “Based on the success story of electroceutical and digital therapeutics STO, we plan to gradually expand our scope.”

A Gyeongnam Pharmaceutical official said, “We expect liquidity supply to be facilitated through token securities issuance during the research and development process of digital therapeutics and electroceuticals, and we will actively cooperate with Blade Ent to develop the business model.”

In particular, starting from the first half of next year, as secondary market trading of fractional investment securities becomes possible, various STO projects promoted by Blade Ent are expected to gain further momentum.

The day before, the Financial Services Commission newly designated 10 cases, including the “opening of a secondary market for new securities using fractional investment methods,” as innovative financial services (financial regulatory sandbox). New securities using fractional investment methods are products based on high-priced artworks, copyrights, real estate, etc., which are generally difficult for ordinary investors to access. With this innovative financial service designation, investors can now conduct fractional investment trading using the exchange securities market system.

Blade Ent has been closely watching the potential of the token securities market and has been promoting STO projects in various fields early on.

In June, Blade Ent entered the token securities business in partnership with major domestic financial institutions, and recently agreed to collaborate with Green Whale E&M, a waste landfill business company, on a “landfill token securities” project. Additionally, it plans to develop a valuation model based on its K-content (films, dramas, etc.) as underlying assets in cooperation with Korea Ratings.

Researcher Yuseongman from Leading Investment Securities said, “Blade Ent is currently actively promoting the STO business based on its content IP (intellectual property),” and added, “Through full-scale collaboration with financial institutions such as NH Nonghyup Bank and Kiwoom Securities, secondary market circulation is expected to be possible as early as this year.”

He continued, “They are also conducting full-scale K-content IP expansion projects, including K-POP idol debuts through subsidiaries, film production, and joint investments,” and analyzed, “Starting next year, when both online and offline content become fully active, performance and momentum are expected to increase.”

This content was produced with the assistance of AI translation services.